# FDA recall D-420-2013

> **Novartis Consumer Health** · Class III · drug recall initiated 2013-04-19.

## Product

Lamisil AT (terbinafine hydrochloride cream 1% antifungal), 24 g (.85 oz) tube, Novartis Consumer Health, Parsippany, NJ 07054, NDC 0067-6171-85

## Reason for recall

Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-420-2013
- **Recalling firm:** Novartis Consumer Health
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-04-19
- **Report date:** 2013-05-29
- **Termination date:** 2014-11-04

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lincoln, NE, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-420-2013

## Citation

> AI Analytics. FDA recall D-420-2013. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-420-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*
